Compare CRNX & SBRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRNX | SBRA |
|---|---|---|
| Founded | 2008 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.8B |
| IPO Year | 2018 | N/A |
| Metric | CRNX | SBRA |
|---|---|---|
| Price | $55.90 | $19.18 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 8 |
| Target Price | ★ $73.70 | $20.63 |
| AVG Volume (30 Days) | 1.6M | ★ 2.5M |
| Earning Date | 02-26-2026 | 02-18-2026 |
| Dividend Yield | N/A | ★ 6.24% |
| EPS Growth | N/A | ★ 78.50 |
| EPS | N/A | ★ 0.73 |
| Revenue | $1,535,000.00 | ★ $747,056,000.00 |
| Revenue This Year | $425.41 | $6.17 |
| Revenue Next Year | $943.30 | $5.24 |
| P/E Ratio | ★ N/A | $26.41 |
| Revenue Growth | ★ 47.74 | 9.34 |
| 52 Week Low | $24.10 | $15.60 |
| 52 Week High | $57.99 | $19.97 |
| Indicator | CRNX | SBRA |
|---|---|---|
| Relative Strength Index (RSI) | 65.78 | 51.83 |
| Support Level | $53.45 | $19.21 |
| Resistance Level | $56.23 | $19.49 |
| Average True Range (ATR) | 3.09 | 0.40 |
| MACD | 0.60 | -0.01 |
| Stochastic Oscillator | 84.22 | 56.85 |
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.